Casegravol

CAS No. 74474-76-3

Casegravol( —— )

Catalog No. M32689 CAS No. 74474-76-3

Casegravol shows antiproliferative activity against human gastric adenocarcinoma (MK-1), human uterus carcinoma (HeLa), and murine melanoma (B16F10) cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 2280 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Casegravol
  • Note
    Research use only, not for human use.
  • Brief Description
    Casegravol shows antiproliferative activity against human gastric adenocarcinoma (MK-1), human uterus carcinoma (HeLa), and murine melanoma (B16F10) cells.
  • Description
    Casegravol shows antiproliferative activity against human gastric adenocarcinoma (MK-1), human uterus carcinoma (HeLa), and murine melanoma (B16F10) cells.Casegravo can be isolated from Boenninghausenia japonica. Casegravo has anti-cell proliferation activity and can be used in cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    74474-76-3
  • Formula Weight
    276.28
  • Molecular Formula
    C15H16O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Etelcalcetide

    Etelcalcetide (AMG 416) is a synthetic peptide as an activator of the calcium sensing receptor (CaSR). Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis.

  • 2-Phenyl-2-(1-piperi...

    2-Phenyl-2-(1-piperidinyl)propane (PPP) an analog of phencyclidine.

  • SI 60

    Sanaid SI 60 is an aromatic sulfonium salt and is initiator for thermosetting polymerization at low temperature.